Repetitive Transcranial Magnetic Stimulation in Patient Care

The place of repetitive transcranial magnetic stimulation (rTMS) in the treatment for patients with major depressive disorder and the future.

A talk by Professor Paul Fitzgerald, Professor of Psychiatry and Director of the Epworth Centre for Innovation in Mental Health at Epworth Healthcare and the Monash University Central Clinical School.

Join us on Tuesday, 19 April 2022 6:00 PM – 7:00 PM AEST. Register on eventbrite

Despite more than twenty-five years of research establishing the antidepressant efficacy and safety of repetitive transcranial magnetic stimulation (rTMS), there remains uncertainty about the depth and breadth of this evidence base resulting in confusion as to where rTMS fits in the therapeutic armamentarium in the management of patients with mood disorders. This presentation will review the evidence supporting the use if rTMS: how it compares to placebo stimulation and alternative treatment options for patients with treatment resistant depression.